Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection-Reference-Cited by-同舟云学术

Evidence of Failure of Oral Third-Generation Cephalosporin Treatment for Shigella sonnei Infection

Published:2020-04-01 Issue:4 Volume:7 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Collins Jennifer P¹²,Friedman Cindy R²,Birhane Meseret G²,Karp Beth E²,Osinski Anthony³,Montgomery Mary W⁴,Thomas Deepam⁵,Barkley Jonathan⁶,Sanchez Martha C⁷,Hanna Samir⁸,Adediran Azizat A⁹,Chen Jessica C⁹,Caidi Hayat⁹,Francois Watkins Louise²

Affiliation:

1. Epidemic Intelligence Service, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

2. Enteric Diseases Epidemiology Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

3. Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Boston, Massachusetts, USA

4. Brigham and Women’s Hospital, Division of Infectious Diseases, Boston, Massachusetts, USA

5. New Jersey Department of Health, Communicable Disease Service, Trenton, New Jersey, USA

6. Rhode Island Department of Health, Center for Acute Infectious Disease Epidemiology, Providence, Rhode Island, USA

7. Brown Medicine, Division of Infectious Diseases, Providence, Rhode Island, USA

8. Tennessee Department of Health, Communicable and Environmental Diseases and Emergency Preparedness, Nashville, Tennessee, USA

9. Enteric Diseases Laboratory Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Abstract

Abstract In 2017, state health departments notified the Centers for Disease Control and Prevention about 4 patients with shigellosis who experienced persistent illness after treatment with oral third-generation cephalosporins. Given increasing antibiotic resistance among Shigella, these cases highlight the need to evaluate the efficacy of oral cephalosporins for shigellosis.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

http://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofaa113/33004957/ofaa113.pdf

Reference12 articles.

1. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea;Shane;Clin Infect Dis,2017

2. Shigellosis;Kotloff;Lancet,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolution and international spread of extensively drug resistant Shigella sonnei;Nature Communications;2023-04-08

2. The evolution and international spread of extensively drug resistant Shigella sonnei;2022-09-15

3. Evaluation of a Live Attenuated S. sonnei Vaccine Strain in the Human Enteroid Model;Pathogens;2021-08-25

4. Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community—Vermont, 2018;Clinical Infectious Diseases;2021-05-16

5. Multiple drugs;Reactions Weekly;2021-05